BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galati F, Moffa G, Pediconi F. Breast imaging: Beyond the detection. Eur J Radiol 2022;146:110051. [PMID: 34864426 DOI: 10.1016/j.ejrad.2021.110051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Wekking D, Porcu M, De Silva P, Saba L, Scartozzi M, Solinas C. Breast MRI: Clinical Indications, Recommendations, and Future Applications in Breast Cancer Diagnosis. Curr Oncol Rep 2023. [PMID: 36749493 DOI: 10.1007/s11912-023-01372-x] [Reference Citation Analysis]
2 Galati F, Magri V, Arias-Cadena PA, Moffa G, Rizzo V, Pasculli M, Botticelli A, Pediconi F. Pregnancy-Associated Breast Cancer: A Diagnostic and Therapeutic Challenge. Diagnostics (Basel) 2023;13. [PMID: 36832092 DOI: 10.3390/diagnostics13040604] [Reference Citation Analysis]
3 Mattusch C, Bick U, Michallek F. Development and validation of a four-dimensional registration technique for DCE breast MRI. Insights Imaging 2023;14:17. [PMID: 36701001 DOI: 10.1186/s13244-022-01362-w] [Reference Citation Analysis]
4 Felipe VC, Barbosa PNVP, Chojniak R, Bitencourt AGV. Iodinated Contrast Enhancement of Breast Cancer on Prone Multidetector Computed Tomography-Preliminary Findings. J Comput Assist Tomogr 2023;47:45-9. [PMID: 36219728 DOI: 10.1097/RCT.0000000000001385] [Reference Citation Analysis]
5 Galati F, Magri V, Moffa G, Rizzo V, Botticelli A, Cortesi E, Pediconi F. Precision Medicine in Breast Cancer: Do MRI Biomarkers Identify Patients Who Truly Benefit from the Oncotype DX Recurrence Score(®) Test? Diagnostics (Basel) 2022;12. [PMID: 36359573 DOI: 10.3390/diagnostics12112730] [Reference Citation Analysis]
6 Gu J, Jiang T. Ultrasound radiomics in personalized breast management: Current status and future prospects. Front Oncol 2022;12:963612. [DOI: 10.3389/fonc.2022.963612] [Reference Citation Analysis]